Position in ABBV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$15,395,586
+$2,535,403 QoQ
Shares Held
61,181
+3.5% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.66%
of 13F equity value
Holder Rank
#729
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Empirical Finance, LLC holds $104,508,931 across 9 Drug Manufacturers - General names. ABBV ranks #3 (14.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
27,524 | $33,013,114 | |
| 2 | JNJ |
Johnson & Johnson
|
85,199 | $21,637,990 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
61,181 | $15,395,586 | |
| 4 | MRK |
Merck & Co., Inc.
|
93,774 | $12,049,959 | |
| 5 | AMGN |
Amgen Inc
|
18,865 | $6,831,393 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
43,580 | $5,505,897 | |
| 7 | PFE |
Pfizer Inc
|
197,099 | $4,746,143 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
72,834 | $4,196,695 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,395,586 | 61,181 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $12,860,183 | 59,130 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $13,533,234 | 59,229 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $14,323,527 | 61,862 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $11,372,194 | 61,266 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $12,754,530 | 60,875 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $10,688,299 | 60,148 | Shares | Sole | 2025-01-28 | |
| 2024-09-30 | $12,034,036 | 60,938 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $10,228,595 | 59,635 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $11,594,671 | 63,672 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $9,535,923 | 61,534 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $9,118,000 | 61,170 | Shares | Sole | 2023-11-02 | |
| 2023-06-30 | $7,441,676 | 55,234 | Shares | Sole | 2023-07-27 | |
| 2023-03-31 | $7,824,110 | 49,094 | Shares | Sole | 2023-04-05 | |
| 2022-12-31 | $7,462,664 | 46,177 | Shares | Sole | 2023-02-21 | |
| 2022-09-30 | $5,685,135 | 42,360 | Shares | Sole | 2022-11-04 | |
| 2022-06-30 | $5,440,549 | 35,522 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $5,447,220 | 33,602 | Shares | Sole | 2022-04-21 | |
| 2021-12-31 | $4,046,835 | 29,888 | Shares | Sole | 2022-02-04 | |
| 2021-09-30 | $2,343,691 | 21,727 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,971,200 | 17,500 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $1,893,850 | 17,500 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $1,875,125 | 17,500 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $1,255,690 | 14,336 | Shares | Sole | 2020-10-28 | |
| 2020-06-30 | $2,116,564 | 21,558 | Shares | Sole | 2020-07-20 | |
| 2020-03-31 | $1,886,312 | 24,758 | Shares | Sole | 2020-04-16 | |
| No filing history on record for this holder in this stock. | ||||||